Scipher Medicine

Discovery Tools (Healthcare) · Waltham, MA · Founded 2013 · Privately Held (backing)

Developer of diagnostics and a precision medicine platform designed for therapy selection and drug development in autoimmune diseases. Scipher Medicine is based in Waltham, MA and was founded in 2013. Its last known valuation is $496 million. It has raised $232 million across 6 recorded rounds; the latest was a $5.8 million early-stage round in May 2024.

Last price · $/share
—
Implied valuation
$495.9M
Total raised
$232.0M
Last round
Early Stage VC
May 2024
What is Scipher Medicine worth?
$495.9Mlast known valuation

Scipher Medicine last raised $5.8M in its Early Stage VC (May 2024).

Free account
More of Scipher Medicine with a free account
  • ·The complete investor list: 18 names
  • ·Watch Scipher Medicine: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Scipher Medicine funding history

6 rounds
DateRoundRaisedPost-money
May 2024Early Stage VC$5.8M▮
Mar 2021Later Stage VC$82.0M▮
May 2019Early Stage VC$25.0M▮
Aug 2018Early Stage VC$8.5M▮
May 2018Debt$795K▮
Jan 2018Accelerator/Incubator—▮
Unlock post-money valuations

Membership and data by Private Market View

Scipher Medicine valuation

Scipher Medicine's last known valuation is $496 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Scipher Medicine raised?

Scipher Medicine has raised $232 million across 6 recorded rounds since 2018. The largest was an $8.5 million early-stage round in Aug 2018; the most recent was a $5.8 million early-stage round in May 2024.

Scipher Medicine has filed 7 Form Ds with the SEC since 2018, most recently in Jul 2024 ($5.8 million sold to 1 investor).

Comparable companies

Comparable discovery tools (healthcare) names by valuation on PrivateMarketView: TRIANA Biomedicines ($258 million), Outpace Bio ($220 million) and Nature's Toolbox ($71 million).

How Scipher Medicine's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Scipher Medicine, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Scipher Medicine

What is Scipher Medicine worth?
Scipher Medicine's last known valuation is $495.9M.
How much has Scipher Medicine raised?
Scipher Medicine has raised $232.0M in total funding across 6 recorded rounds.
When did Scipher Medicine last raise?
Scipher Medicine last raised in May 2024 (Early Stage VC), raising $5.8M.